nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOB—Dopamine metabolism—TYR—skin cancer	0.0252	0.585	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—TYR—skin cancer	0.0158	0.367	CbGpPWpGaD
Linezolid—MAOB—nerve—skin cancer	0.00928	0.166	CbGeAlD
Linezolid—MAOA—nerve—skin cancer	0.00792	0.142	CbGeAlD
Linezolid—MAOB—nipple—skin cancer	0.00527	0.0943	CbGeAlD
Linezolid—MAOA—nipple—skin cancer	0.0045	0.0805	CbGeAlD
Linezolid—MAOA—neck—skin cancer	0.00445	0.0796	CbGeAlD
Linezolid—MAOB—connective tissue—skin cancer	0.00374	0.0669	CbGeAlD
Linezolid—MAOA—connective tissue—skin cancer	0.00319	0.0571	CbGeAlD
Linezolid—MAOB—mammalian vulva—skin cancer	0.00308	0.0551	CbGeAlD
Linezolid—Nausea—Vismodegib—skin cancer	0.00294	0.00326	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00293	0.00325	CcSEcCtD
Linezolid—Pneumonia—Bleomycin—skin cancer	0.00292	0.00324	CcSEcCtD
Linezolid—Angioedema—Imiquimod—skin cancer	0.00292	0.00324	CcSEcCtD
Linezolid—Hypokalaemia—Temozolomide—skin cancer	0.00289	0.00321	CcSEcCtD
Linezolid—Pancytopenia—Dactinomycin—skin cancer	0.00288	0.0032	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00286	0.00317	CcSEcCtD
Linezolid—Neutropenia—Dactinomycin—skin cancer	0.00284	0.00315	CcSEcCtD
Linezolid—Stomatitis—Bleomycin—skin cancer	0.00283	0.00314	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Temozolomide—skin cancer	0.0028	0.00311	CcSEcCtD
Linezolid—Cough—Imiquimod—skin cancer	0.00279	0.00309	CcSEcCtD
Linezolid—Candida infection—Docetaxel—skin cancer	0.00278	0.00308	CcSEcCtD
Linezolid—Convulsion—Imiquimod—skin cancer	0.00277	0.00307	CcSEcCtD
Linezolid—Fluid retention—Docetaxel—skin cancer	0.00276	0.00307	CcSEcCtD
Linezolid—Hypertension—Imiquimod—skin cancer	0.00276	0.00306	CcSEcCtD
Linezolid—Neuropathy—Docetaxel—skin cancer	0.00273	0.00303	CcSEcCtD
Linezolid—Pneumonia—Dactinomycin—skin cancer	0.00272	0.00302	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00268	0.00298	CcSEcCtD
Linezolid—Sweating increased—Temozolomide—skin cancer	0.00267	0.00297	CcSEcCtD
Linezolid—Dry mouth—Imiquimod—skin cancer	0.00266	0.00295	CcSEcCtD
Linezolid—Decreased appetite—Vemurafenib—skin cancer	0.00266	0.00295	CcSEcCtD
Linezolid—Stomatitis—Dactinomycin—skin cancer	0.00264	0.00293	CcSEcCtD
Linezolid—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00264	0.00293	CcSEcCtD
Linezolid—MAOB—female reproductive system—skin cancer	0.00264	0.0472	CbGeAlD
Linezolid—Fatigue—Vemurafenib—skin cancer	0.00263	0.00292	CcSEcCtD
Linezolid—MAOA—mammalian vulva—skin cancer	0.00263	0.047	CbGeAlD
Linezolid—Haemoglobin—Bleomycin—skin cancer	0.00262	0.00291	CcSEcCtD
Linezolid—Constipation—Vemurafenib—skin cancer	0.00261	0.0029	CcSEcCtD
Linezolid—Pancytopenia—Temozolomide—skin cancer	0.00261	0.00289	CcSEcCtD
Linezolid—Haemorrhage—Bleomycin—skin cancer	0.00261	0.00289	CcSEcCtD
Linezolid—Hypoaesthesia—Bleomycin—skin cancer	0.00259	0.00288	CcSEcCtD
Linezolid—Neutropenia—Temozolomide—skin cancer	0.00257	0.00285	CcSEcCtD
Linezolid—Upper respiratory tract infection—Temozolomide—skin cancer	0.00255	0.00283	CcSEcCtD
Linezolid—Skin disorder—Imiquimod—skin cancer	0.00253	0.00281	CcSEcCtD
Linezolid—Sepsis—Docetaxel—skin cancer	0.00253	0.0028	CcSEcCtD
Linezolid—Hyperhidrosis—Imiquimod—skin cancer	0.00252	0.0028	CcSEcCtD
Linezolid—Eosinophilia—Fluorouracil—skin cancer	0.0025	0.00278	CcSEcCtD
Linezolid—Anorexia—Imiquimod—skin cancer	0.00248	0.00276	CcSEcCtD
Linezolid—Hyperglycaemia—Temozolomide—skin cancer	0.00248	0.00275	CcSEcCtD
Linezolid—Pneumonia—Temozolomide—skin cancer	0.00246	0.00273	CcSEcCtD
Linezolid—Phlebitis—Docetaxel—skin cancer	0.00245	0.00272	CcSEcCtD
Linezolid—Thrombophlebitis—Docetaxel—skin cancer	0.00244	0.00271	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00243	0.00269	CcSEcCtD
Linezolid—Body temperature increased—Vemurafenib—skin cancer	0.00241	0.00268	CcSEcCtD
Linezolid—Pharyngitis—Dactinomycin—skin cancer	0.00241	0.00268	CcSEcCtD
Linezolid—Pancytopenia—Fluorouracil—skin cancer	0.0024	0.00267	CcSEcCtD
Linezolid—Neuropathy peripheral—Temozolomide—skin cancer	0.0024	0.00266	CcSEcCtD
Linezolid—Stomatitis—Temozolomide—skin cancer	0.00239	0.00265	CcSEcCtD
Linezolid—Insomnia—Imiquimod—skin cancer	0.00236	0.00262	CcSEcCtD
Linezolid—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00235	0.00261	CcSEcCtD
Linezolid—Paraesthesia—Imiquimod—skin cancer	0.00234	0.0026	CcSEcCtD
Linezolid—Chills—Bleomycin—skin cancer	0.00234	0.00259	CcSEcCtD
Linezolid—Cardiac failure congestive—Docetaxel—skin cancer	0.00233	0.00259	CcSEcCtD
Linezolid—Dyspnoea—Imiquimod—skin cancer	0.00232	0.00258	CcSEcCtD
Linezolid—Somnolence—Imiquimod—skin cancer	0.00232	0.00257	CcSEcCtD
Linezolid—Erythema multiforme—Dactinomycin—skin cancer	0.0023	0.00255	CcSEcCtD
Linezolid—Dyspepsia—Imiquimod—skin cancer	0.00229	0.00255	CcSEcCtD
Linezolid—Pneumonia—Fluorouracil—skin cancer	0.00227	0.00252	CcSEcCtD
Linezolid—Erythema—Bleomycin—skin cancer	0.00227	0.00252	CcSEcCtD
Linezolid—Decreased appetite—Imiquimod—skin cancer	0.00226	0.00251	CcSEcCtD
Linezolid—Gastrointestinal disorder—Imiquimod—skin cancer	0.00225	0.0025	CcSEcCtD
Linezolid—MAOA—female reproductive system—skin cancer	0.00225	0.0402	CbGeAlD
Linezolid—Fatigue—Imiquimod—skin cancer	0.00225	0.00249	CcSEcCtD
Linezolid—Pain—Imiquimod—skin cancer	0.00223	0.00247	CcSEcCtD
Linezolid—Neuropathy peripheral—Fluorouracil—skin cancer	0.00221	0.00245	CcSEcCtD
Linezolid—Haemoglobin—Temozolomide—skin cancer	0.00221	0.00245	CcSEcCtD
Linezolid—MAOB—head—skin cancer	0.0022	0.0394	CbGeAlD
Linezolid—Stomatitis—Fluorouracil—skin cancer	0.0022	0.00244	CcSEcCtD
Linezolid—Haemorrhage—Temozolomide—skin cancer	0.0022	0.00244	CcSEcCtD
Linezolid—Asthenia—Vemurafenib—skin cancer	0.00219	0.00243	CcSEcCtD
Linezolid—Hypoaesthesia—Temozolomide—skin cancer	0.00219	0.00243	CcSEcCtD
Linezolid—Pharyngitis—Temozolomide—skin cancer	0.00218	0.00242	CcSEcCtD
Linezolid—Chills—Dactinomycin—skin cancer	0.00218	0.00242	CcSEcCtD
Linezolid—Pruritus—Vemurafenib—skin cancer	0.00216	0.0024	CcSEcCtD
Linezolid—Gastrointestinal pain—Imiquimod—skin cancer	0.00213	0.00236	CcSEcCtD
Linezolid—Hyponatraemia—Docetaxel—skin cancer	0.00212	0.00235	CcSEcCtD
Linezolid—Erythema—Dactinomycin—skin cancer	0.00212	0.00235	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00211	0.00234	CcSEcCtD
Linezolid—Anaemia—Bleomycin—skin cancer	0.0021	0.00233	CcSEcCtD
Linezolid—Diarrhoea—Vemurafenib—skin cancer	0.00209	0.00232	CcSEcCtD
Linezolid—Erythema multiforme—Temozolomide—skin cancer	0.00208	0.00231	CcSEcCtD
Linezolid—Urticaria—Imiquimod—skin cancer	0.00207	0.0023	CcSEcCtD
Linezolid—Body temperature increased—Imiquimod—skin cancer	0.00206	0.00229	CcSEcCtD
Linezolid—Abdominal pain—Imiquimod—skin cancer	0.00206	0.00229	CcSEcCtD
Linezolid—Tinnitus—Temozolomide—skin cancer	0.00205	0.00227	CcSEcCtD
Linezolid—Haemoglobin—Fluorouracil—skin cancer	0.00204	0.00226	CcSEcCtD
Linezolid—Leukopenia—Bleomycin—skin cancer	0.00203	0.00225	CcSEcCtD
Linezolid—Haemorrhage—Fluorouracil—skin cancer	0.00202	0.00225	CcSEcCtD
Linezolid—Dizziness—Vemurafenib—skin cancer	0.00202	0.00224	CcSEcCtD
Linezolid—Hypoaesthesia—Fluorouracil—skin cancer	0.00201	0.00224	CcSEcCtD
Linezolid—Pharyngitis—Fluorouracil—skin cancer	0.00201	0.00223	CcSEcCtD
Linezolid—Cough—Bleomycin—skin cancer	0.00198	0.0022	CcSEcCtD
Linezolid—Chills—Temozolomide—skin cancer	0.00197	0.00219	CcSEcCtD
Linezolid—Anaemia—Dactinomycin—skin cancer	0.00195	0.00217	CcSEcCtD
Linezolid—Liver function test abnormal—Docetaxel—skin cancer	0.00195	0.00216	CcSEcCtD
Linezolid—Vomiting—Vemurafenib—skin cancer	0.00194	0.00216	CcSEcCtD
Linezolid—Rash—Vemurafenib—skin cancer	0.00193	0.00214	CcSEcCtD
Linezolid—Dermatitis—Vemurafenib—skin cancer	0.00192	0.00214	CcSEcCtD
Linezolid—Headache—Vemurafenib—skin cancer	0.00191	0.00212	CcSEcCtD
Linezolid—Erythema—Temozolomide—skin cancer	0.00191	0.00212	CcSEcCtD
Linezolid—Cramp muscle—Docetaxel—skin cancer	0.0019	0.00211	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.0019	0.00211	CcSEcCtD
Linezolid—Leukopenia—Dactinomycin—skin cancer	0.00189	0.0021	CcSEcCtD
Linezolid—MAOA—head—skin cancer	0.00188	0.0336	CbGeAlD
Linezolid—Dysgeusia—Temozolomide—skin cancer	0.00187	0.00208	CcSEcCtD
Linezolid—Asthenia—Imiquimod—skin cancer	0.00187	0.00207	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00186	0.00207	CcSEcCtD
Linezolid—Anaphylactic shock—Bleomycin—skin cancer	0.00185	0.00205	CcSEcCtD
Linezolid—Pruritus—Imiquimod—skin cancer	0.00184	0.00205	CcSEcCtD
Linezolid—Nausea—Vemurafenib—skin cancer	0.00181	0.00201	CcSEcCtD
Linezolid—Thrombocytopenia—Bleomycin—skin cancer	0.00181	0.00201	CcSEcCtD
Linezolid—Vision blurred—Temozolomide—skin cancer	0.0018	0.002	CcSEcCtD
Linezolid—Diarrhoea—Imiquimod—skin cancer	0.00178	0.00198	CcSEcCtD
Linezolid—Anaemia—Temozolomide—skin cancer	0.00177	0.00196	CcSEcCtD
Linezolid—Anorexia—Bleomycin—skin cancer	0.00176	0.00196	CcSEcCtD
Linezolid—Erythema—Fluorouracil—skin cancer	0.00176	0.00196	CcSEcCtD
Linezolid—Angioedema—Temozolomide—skin cancer	0.00175	0.00194	CcSEcCtD
Linezolid—Pancytopenia—Docetaxel—skin cancer	0.00173	0.00192	CcSEcCtD
Linezolid—Dizziness—Imiquimod—skin cancer	0.00172	0.00191	CcSEcCtD
Linezolid—Vertigo—Temozolomide—skin cancer	0.00172	0.00191	CcSEcCtD
Linezolid—Leukopenia—Temozolomide—skin cancer	0.00171	0.0019	CcSEcCtD
Linezolid—Neutropenia—Docetaxel—skin cancer	0.00171	0.00189	CcSEcCtD
Linezolid—Thrombocytopenia—Dactinomycin—skin cancer	0.00169	0.00188	CcSEcCtD
Linezolid—Cough—Temozolomide—skin cancer	0.00167	0.00185	CcSEcCtD
Linezolid—Paraesthesia—Bleomycin—skin cancer	0.00166	0.00184	CcSEcCtD
Linezolid—Vision blurred—Fluorouracil—skin cancer	0.00166	0.00184	CcSEcCtD
Linezolid—Convulsion—Temozolomide—skin cancer	0.00166	0.00184	CcSEcCtD
Linezolid—Vomiting—Imiquimod—skin cancer	0.00166	0.00184	CcSEcCtD
Linezolid—Hypertension—Temozolomide—skin cancer	0.00165	0.00183	CcSEcCtD
Linezolid—Dyspnoea—Bleomycin—skin cancer	0.00165	0.00183	CcSEcCtD
Linezolid—Anorexia—Dactinomycin—skin cancer	0.00165	0.00183	CcSEcCtD
Linezolid—Rash—Imiquimod—skin cancer	0.00164	0.00182	CcSEcCtD
Linezolid—Dermatitis—Imiquimod—skin cancer	0.00164	0.00182	CcSEcCtD
Linezolid—Pneumonia—Docetaxel—skin cancer	0.00164	0.00182	CcSEcCtD
Linezolid—Headache—Imiquimod—skin cancer	0.00163	0.00181	CcSEcCtD
Linezolid—Anaemia—Fluorouracil—skin cancer	0.00163	0.00181	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00161	0.00179	CcSEcCtD
Linezolid—Decreased appetite—Bleomycin—skin cancer	0.00161	0.00179	CcSEcCtD
Linezolid—Renal failure—Docetaxel—skin cancer	0.0016	0.00178	CcSEcCtD
Linezolid—Neuropathy peripheral—Docetaxel—skin cancer	0.0016	0.00177	CcSEcCtD
Linezolid—Dry mouth—Temozolomide—skin cancer	0.00159	0.00177	CcSEcCtD
Linezolid—Stomatitis—Docetaxel—skin cancer	0.00159	0.00176	CcSEcCtD
Linezolid—Pain—Bleomycin—skin cancer	0.00158	0.00176	CcSEcCtD
Linezolid—Leukopenia—Fluorouracil—skin cancer	0.00158	0.00175	CcSEcCtD
Linezolid—Anaphylactic shock—Temozolomide—skin cancer	0.00156	0.00173	CcSEcCtD
Linezolid—Nausea—Imiquimod—skin cancer	0.00155	0.00172	CcSEcCtD
Linezolid—MAOB—lymph node—skin cancer	0.00154	0.0276	CbGeAlD
Linezolid—Thrombocytopenia—Temozolomide—skin cancer	0.00153	0.0017	CcSEcCtD
Linezolid—Convulsion—Fluorouracil—skin cancer	0.00153	0.0017	CcSEcCtD
Linezolid—Skin disorder—Temozolomide—skin cancer	0.00152	0.00168	CcSEcCtD
Linezolid—Hyperhidrosis—Temozolomide—skin cancer	0.00151	0.00168	CcSEcCtD
Linezolid—Decreased appetite—Dactinomycin—skin cancer	0.0015	0.00167	CcSEcCtD
Linezolid—Fatigue—Dactinomycin—skin cancer	0.00149	0.00165	CcSEcCtD
Linezolid—Anorexia—Temozolomide—skin cancer	0.00149	0.00165	CcSEcCtD
Linezolid—Pain—Dactinomycin—skin cancer	0.00148	0.00164	CcSEcCtD
Linezolid—Urticaria—Bleomycin—skin cancer	0.00147	0.00163	CcSEcCtD
Linezolid—Haemoglobin—Docetaxel—skin cancer	0.00147	0.00163	CcSEcCtD
Linezolid—Body temperature increased—Bleomycin—skin cancer	0.00146	0.00162	CcSEcCtD
Linezolid—Haemorrhage—Docetaxel—skin cancer	0.00146	0.00162	CcSEcCtD
Linezolid—Hypoaesthesia—Docetaxel—skin cancer	0.00145	0.00161	CcSEcCtD
Linezolid—Pharyngitis—Docetaxel—skin cancer	0.00145	0.00161	CcSEcCtD
Linezolid—Anaphylactic shock—Fluorouracil—skin cancer	0.00144	0.0016	CcSEcCtD
Linezolid—Insomnia—Temozolomide—skin cancer	0.00141	0.00157	CcSEcCtD
Linezolid—Gastrointestinal pain—Dactinomycin—skin cancer	0.00141	0.00157	CcSEcCtD
Linezolid—Thrombocytopenia—Fluorouracil—skin cancer	0.00141	0.00156	CcSEcCtD
Linezolid—Paraesthesia—Temozolomide—skin cancer	0.0014	0.00156	CcSEcCtD
Linezolid—Dyspnoea—Temozolomide—skin cancer	0.00139	0.00154	CcSEcCtD
Linezolid—Somnolence—Temozolomide—skin cancer	0.00139	0.00154	CcSEcCtD
Linezolid—Erythema multiforme—Docetaxel—skin cancer	0.00138	0.00153	CcSEcCtD
Linezolid—Dyspepsia—Temozolomide—skin cancer	0.00137	0.00153	CcSEcCtD
Linezolid—Anorexia—Fluorouracil—skin cancer	0.00137	0.00152	CcSEcCtD
Linezolid—Abdominal pain—Dactinomycin—skin cancer	0.00136	0.00151	CcSEcCtD
Linezolid—Body temperature increased—Dactinomycin—skin cancer	0.00136	0.00151	CcSEcCtD
Linezolid—Decreased appetite—Temozolomide—skin cancer	0.00136	0.00151	CcSEcCtD
Linezolid—Gastrointestinal disorder—Temozolomide—skin cancer	0.00135	0.0015	CcSEcCtD
Linezolid—Fatigue—Temozolomide—skin cancer	0.00135	0.00149	CcSEcCtD
Linezolid—Pain—Temozolomide—skin cancer	0.00134	0.00148	CcSEcCtD
Linezolid—Constipation—Temozolomide—skin cancer	0.00134	0.00148	CcSEcCtD
Linezolid—Asthenia—Bleomycin—skin cancer	0.00133	0.00147	CcSEcCtD
Linezolid—MAOA—lymph node—skin cancer	0.00132	0.0235	CbGeAlD
Linezolid—Chills—Docetaxel—skin cancer	0.00131	0.00146	CcSEcCtD
Linezolid—Pruritus—Bleomycin—skin cancer	0.00131	0.00145	CcSEcCtD
Linezolid—Insomnia—Fluorouracil—skin cancer	0.0013	0.00144	CcSEcCtD
Linezolid—Paraesthesia—Fluorouracil—skin cancer	0.00129	0.00143	CcSEcCtD
Linezolid—Dyspnoea—Fluorouracil—skin cancer	0.00128	0.00142	CcSEcCtD
Linezolid—Somnolence—Fluorouracil—skin cancer	0.00128	0.00142	CcSEcCtD
Linezolid—Gastrointestinal pain—Temozolomide—skin cancer	0.00128	0.00142	CcSEcCtD
Linezolid—Erythema—Docetaxel—skin cancer	0.00127	0.00141	CcSEcCtD
Linezolid—Dyspepsia—Fluorouracil—skin cancer	0.00127	0.00141	CcSEcCtD
Linezolid—Decreased appetite—Fluorouracil—skin cancer	0.00125	0.00139	CcSEcCtD
Linezolid—Dysgeusia—Docetaxel—skin cancer	0.00125	0.00138	CcSEcCtD
Linezolid—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00124	0.00138	CcSEcCtD
Linezolid—Urticaria—Temozolomide—skin cancer	0.00124	0.00138	CcSEcCtD
Linezolid—Asthenia—Dactinomycin—skin cancer	0.00124	0.00137	CcSEcCtD
Linezolid—Abdominal pain—Temozolomide—skin cancer	0.00123	0.00137	CcSEcCtD
Linezolid—Body temperature increased—Temozolomide—skin cancer	0.00123	0.00137	CcSEcCtD
Linezolid—Pain—Fluorouracil—skin cancer	0.00123	0.00137	CcSEcCtD
Linezolid—Muscle spasms—Docetaxel—skin cancer	0.00122	0.00136	CcSEcCtD
Linezolid—Diarrhoea—Dactinomycin—skin cancer	0.00118	0.00131	CcSEcCtD
Linezolid—Vomiting—Bleomycin—skin cancer	0.00118	0.00131	CcSEcCtD
Linezolid—Anaemia—Docetaxel—skin cancer	0.00118	0.00131	CcSEcCtD
Linezolid—Rash—Bleomycin—skin cancer	0.00117	0.0013	CcSEcCtD
Linezolid—Dermatitis—Bleomycin—skin cancer	0.00117	0.00129	CcSEcCtD
Linezolid—Urticaria—Fluorouracil—skin cancer	0.00114	0.00127	CcSEcCtD
Linezolid—Leukopenia—Docetaxel—skin cancer	0.00114	0.00126	CcSEcCtD
Linezolid—Body temperature increased—Fluorouracil—skin cancer	0.00114	0.00126	CcSEcCtD
Linezolid—Asthenia—Temozolomide—skin cancer	0.00112	0.00124	CcSEcCtD
Linezolid—Cough—Docetaxel—skin cancer	0.00111	0.00123	CcSEcCtD
Linezolid—Pruritus—Temozolomide—skin cancer	0.0011	0.00123	CcSEcCtD
Linezolid—Convulsion—Docetaxel—skin cancer	0.0011	0.00122	CcSEcCtD
Linezolid—Nausea—Bleomycin—skin cancer	0.0011	0.00122	CcSEcCtD
Linezolid—Hypertension—Docetaxel—skin cancer	0.0011	0.00122	CcSEcCtD
Linezolid—Vomiting—Dactinomycin—skin cancer	0.0011	0.00122	CcSEcCtD
Linezolid—Rash—Dactinomycin—skin cancer	0.00109	0.00121	CcSEcCtD
Linezolid—Diarrhoea—Temozolomide—skin cancer	0.00107	0.00119	CcSEcCtD
Linezolid—Dry mouth—Docetaxel—skin cancer	0.00106	0.00118	CcSEcCtD
Linezolid—Anaphylactic shock—Docetaxel—skin cancer	0.00104	0.00115	CcSEcCtD
Linezolid—Dizziness—Temozolomide—skin cancer	0.00103	0.00115	CcSEcCtD
Linezolid—Nausea—Dactinomycin—skin cancer	0.00103	0.00114	CcSEcCtD
Linezolid—Pruritus—Fluorouracil—skin cancer	0.00102	0.00113	CcSEcCtD
Linezolid—Thrombocytopenia—Docetaxel—skin cancer	0.00102	0.00113	CcSEcCtD
Linezolid—Skin disorder—Docetaxel—skin cancer	0.00101	0.00112	CcSEcCtD
Linezolid—Vomiting—Temozolomide—skin cancer	0.000993	0.0011	CcSEcCtD
Linezolid—Anorexia—Docetaxel—skin cancer	0.00099	0.0011	CcSEcCtD
Linezolid—Rash—Temozolomide—skin cancer	0.000984	0.00109	CcSEcCtD
Linezolid—Diarrhoea—Fluorouracil—skin cancer	0.000984	0.00109	CcSEcCtD
Linezolid—Dermatitis—Temozolomide—skin cancer	0.000983	0.00109	CcSEcCtD
Linezolid—Headache—Temozolomide—skin cancer	0.000978	0.00109	CcSEcCtD
Linezolid—Dizziness—Fluorouracil—skin cancer	0.000951	0.00106	CcSEcCtD
Linezolid—Insomnia—Docetaxel—skin cancer	0.000939	0.00104	CcSEcCtD
Linezolid—Paraesthesia—Docetaxel—skin cancer	0.000932	0.00103	CcSEcCtD
Linezolid—Nausea—Temozolomide—skin cancer	0.000927	0.00103	CcSEcCtD
Linezolid—Dyspnoea—Docetaxel—skin cancer	0.000926	0.00103	CcSEcCtD
Linezolid—Somnolence—Docetaxel—skin cancer	0.000923	0.00102	CcSEcCtD
Linezolid—Vomiting—Fluorouracil—skin cancer	0.000915	0.00102	CcSEcCtD
Linezolid—Dyspepsia—Docetaxel—skin cancer	0.000914	0.00101	CcSEcCtD
Linezolid—Rash—Fluorouracil—skin cancer	0.000907	0.00101	CcSEcCtD
Linezolid—Dermatitis—Fluorouracil—skin cancer	0.000906	0.00101	CcSEcCtD
Linezolid—Decreased appetite—Docetaxel—skin cancer	0.000903	0.001	CcSEcCtD
Linezolid—Headache—Fluorouracil—skin cancer	0.000901	0.001	CcSEcCtD
Linezolid—Gastrointestinal disorder—Docetaxel—skin cancer	0.000896	0.000995	CcSEcCtD
Linezolid—Fatigue—Docetaxel—skin cancer	0.000895	0.000994	CcSEcCtD
Linezolid—Pain—Docetaxel—skin cancer	0.000888	0.000985	CcSEcCtD
Linezolid—Constipation—Docetaxel—skin cancer	0.000888	0.000985	CcSEcCtD
Linezolid—Nausea—Fluorouracil—skin cancer	0.000854	0.000948	CcSEcCtD
Linezolid—Gastrointestinal pain—Docetaxel—skin cancer	0.000849	0.000942	CcSEcCtD
Linezolid—Abdominal pain—Docetaxel—skin cancer	0.000821	0.000911	CcSEcCtD
Linezolid—Body temperature increased—Docetaxel—skin cancer	0.000821	0.000911	CcSEcCtD
Linezolid—Asthenia—Docetaxel—skin cancer	0.000745	0.000827	CcSEcCtD
Linezolid—Pruritus—Docetaxel—skin cancer	0.000735	0.000815	CcSEcCtD
Linezolid—Diarrhoea—Docetaxel—skin cancer	0.00071	0.000788	CcSEcCtD
Linezolid—Dizziness—Docetaxel—skin cancer	0.000687	0.000762	CcSEcCtD
Linezolid—Vomiting—Docetaxel—skin cancer	0.00066	0.000733	CcSEcCtD
Linezolid—Rash—Docetaxel—skin cancer	0.000655	0.000727	CcSEcCtD
Linezolid—Dermatitis—Docetaxel—skin cancer	0.000654	0.000726	CcSEcCtD
Linezolid—Headache—Docetaxel—skin cancer	0.00065	0.000722	CcSEcCtD
Linezolid—Nausea—Docetaxel—skin cancer	0.000617	0.000685	CcSEcCtD
Linezolid—MAOB—Metabolism—PLIN2—skin cancer	0.000295	0.00684	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CSPG4—skin cancer	0.000238	0.00551	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—BRAF—skin cancer	0.000227	0.00526	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLIN2—skin cancer	0.000185	0.00429	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—BRAF—skin cancer	0.000174	0.00403	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ENO2—skin cancer	0.000162	0.00375	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CSPG4—skin cancer	0.000149	0.00346	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—skin cancer	0.000122	0.00282	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—HRAS—skin cancer	0.000104	0.00242	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ENO2—skin cancer	0.000102	0.00235	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ERCC2—skin cancer	9.4e-05	0.00218	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—HRAS—skin cancer	7.99e-05	0.00185	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ERCC2—skin cancer	5.9e-05	0.00137	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—skin cancer	5.63e-05	0.00131	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—skin cancer	3.54e-05	0.000819	CbGpPWpGaD
